https://clinicaltrials.gov/ct2/show/NCT02634307?type=Intr&cond=Multiple+Sclerosis&lupd_s=02%2F25%2F2019&lupd_d=14
Condition : Multiple Sclerosis
Intervention : Drug: ALKS 8700
Sponsor : Alkermes, Inc.
Enrolling by invitation
A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
NCT02634307
Fri, 18 Dec 2015 12:00:00 EST
Last Update Posted: 03/11/19 10:02AM